MedTrace Logo

Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal Morbidity

NCT06892314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-12-30

No results posted yet for this study

Summary

The purpose of this observational study is to measure the association between continuous glucose monitoring (CGM) parameters and perinatal morbidity in offspring of women with type 2 diabetes. Specifically, the study will assess whether gestational age interacts with metabolic control in influencing perinatal morbidity, as well as the impact of the timing of CGM initiation during pregnancy.

Conditions

  • Type 2 Diabetes Mellitus (T2DM)
  • Pregnancy

Interventions

BIOLOGICAL

Exposure to hyperglycemia (type 2 diabetes)

Exposure to hyperglycemia, in the context of type 2 diabetes, as measured by continuous glucose monitoring

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Coralie AMADOU, MD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-15
Primary Completion
2025-11-26
Completion
2025-11-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06892314 on ClinicalTrials.gov